Reimbursement

Medicare-insured patients with heart disease had the greatest access to PCSK9 inhibitors.

Rinku Patel, PharmD, RPh, CEO and founder of KloudScript, discusses the struggle with high-cost specialty medications and the alternatives for providing specialty pharmacy care.

Rina Shah, PharmD, Vice President, Pharmacy Operations and Specialty Pharmacy, Walgreens, speaks to the merits of partnering with continuing education and advocacy organizations.

Varubi indicated for use in combination with other antiemetic agents to treat delayed chemotherapy-induced nausea and vomiting in adults.

Elvin Montanez, PharmD, chief operations officer at BioPlus Specialty Pharmacy, discusses the negative impact of a slow turnaround on patient care.

Approximately 300,000 pharmacists are eligible to vaccinate adult patients in the pharmacy.

Non-adherence to medication regimens is estimated to cost approximately $290 billion dollars in unnecessary medical expenses.

Cancer care at hospitals is significantly more expensive than at community oncology clinics.

Cancer patient Beth Wallace provides advice to patients with leiomyosarcoma, as well as to women with cancer in general.

Consistency among caregivers can be an important factor for patients undergoing treatment for cancer.

New drug approval highlights the need for value-based payment models for Medicare and Medicaid.

Brandon Shank, PharmD, MPH, BCOP, discusses how pharmacists work with patients undergoing chemotherapy through transitions of care.

Whistleblower suits arise from claims for reimbursement under Medicare, Medicaid, or TRICARE.

Bruce A. Feinberg, DO, Vice President and Chief Medical Officer of Cardinal Health Specialty Solutions, discusses the importance of specialty pharmacists in a patient-centric environment.

The future for pharmacy is very lucrative as they press on for provider status.

Top articles of the week from Specialty Pharmacy Times.

Top articles of the week from Specialty Pharmacy Times.

Over the last 20 years, pharmacies have become known immunization destinations.

Specialty drugs must have a proven therapeutic value to be covered by plan sponsors.

Meeting accreditation standards in the temperature-sensitive distribution process requires careful monitoring.

Rheumatoid arthritis carries risks for several comorbidities that can affect organ systems, such as the heart and lungs.

Consolidation and drug costs will play a key role in the future of specialty pharmacy.

Strategic, operational, and legal hurdles must be conquered before implementing this contract.

Clearly defining a patient population is necessary to create a singular care framework.